Friday, December 1, 2023
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Bayer’s Nubeqa™ receives EU approval for additional indication in prostate cancer

admin - 0
Latest Pharma-News

AstraZeneca and Daiichi Sankyo’s Enhertu met prespecified criteria for objective response rate and duration of response

admin - 0
Latest Pharma-News

FDA Outlines Steps to Strengthen Tobacco Program

admin - 0
Latest Pharma-News

AZ’s acquisition with CinCor Pharma completed

admin - 0
Latest Pharma-News

Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance

admin - 0
Latest Pharma-News

FDA Provides Draft Labeling Recommendations for Plant-based Milk Alternatives to Inform Consumers

admin - 0
Latest Pharma-News

FDA Files Civil Money Penalty Complaints Against Four E-Cigarette Product Manufacturers

admin - 0
Latest Pharma-News

Pediatric research at ReSViNET 2023 underscores Beyfortus’ potential to prevent RSV disease in infants

admin - 0
Latest Pharma-News

AZ enters license agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate

admin - 0
Latest Pharma-News

ReSViNet 2023 data reinforce AZ’s commitment to help prevent Respiratory Syncytial Virus in infants

admin - 0
Latest Pharma-News

Opdivo® with CABOMETYX® Shows Durable Survival with Over Three Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma

admin - 0
Latest Pharma-News

Bayer completes acquisition of Blackford Analysis Ltd.

admin - 0
1...456...144Page 5 of 144
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved